切换至 "中华医学电子期刊资源库"

中华介入放射学电子杂志 ›› 2019, Vol. 07 ›› Issue (02) : 151 -154. doi: 10.3877/cma.j.issn.2095-5782.2019.02.004

所属专题: 文献

基础研究

DSA引导下注射聚多卡醇和鱼肝油酸钠硬化剂对比格犬隐静脉的影响
黄晓霞1, 梁奇伟2, 冯惠岗2, 庄炜钊2, 林桂仪2, 王浩2, 邢会杰3, 陈汉威2, 黄益2,(), 李龙4,()   
  1. 1. 511400 广州市番禺区中心医院介入科
    3. 510632 广州,暨南大学
    4. 510507 广州,中国人民武装警察部队广东省总队医院
  • 收稿日期:2019-03-25 出版日期:2019-05-01
  • 通信作者: 黄益, 李龙
  • 基金资助:
    广州市番禺区科信局医疗重大项目(2015-Z03-04、2017-Z04-29)

Effect of DSA-guided injection of polidocanol and sodium morrhuate sclerosing agent on saphenous vein in Beagle Dogs

Xiaoxia Huang1, Qiwei Liang2, Huigang Feng2, Weizhao Zhuang2, Guiyi Lin2, Hao Wang2, Huijie Xing3, Hanwei Chen2, Yi Huang2,(), Long Li4,()   

  1. 1. Ji'nan University, Guangzhou 510000, China
    2. Department of Intervention, Panyu District Central Hospital, Guangzhou 511400, China
    4. Guangdong Provincial General Hospital, Guangzhou 510507, China
引用本文:

黄晓霞, 梁奇伟, 冯惠岗, 庄炜钊, 林桂仪, 王浩, 邢会杰, 陈汉威, 黄益, 李龙. DSA引导下注射聚多卡醇和鱼肝油酸钠硬化剂对比格犬隐静脉的影响[J]. 中华介入放射学电子杂志, 2019, 07(02): 151-154.

Xiaoxia Huang, Qiwei Liang, Huigang Feng, Weizhao Zhuang, Guiyi Lin, Hao Wang, Huijie Xing, Hanwei Chen, Yi Huang, Long Li. Effect of DSA-guided injection of polidocanol and sodium morrhuate sclerosing agent on saphenous vein in Beagle Dogs[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2019, 07(02): 151-154.

目的:

比较DSA引导下注射两种常用泡沫硬化剂聚多卡醇和鱼肝油酸钠对比格犬下肢隐静脉血管璧的组织学损伤。

方法:

成年健康比格犬12只,随机分为聚多卡醇组和鱼肝油酸钠组,每组6只。DSA透视下行隐静脉造影,聚多卡醇组于左前、左后、右后肢注射1%聚多卡醇泡沫硬化剂,鱼肝油酸钠组于左前、左后、右后肢注射5%鱼肝油酸钠泡沫硬化剂。注射后30 min、2 d及28 d,采集隐静脉标本进行HE和Massion染色,光镜下对比观察犬隐静脉血管壁内皮及中膜的组织学变化。

结果:

两种泡沫硬化剂均可致犬隐静脉血管内皮损伤和中膜增厚;注射后30 min,两组病理上均可见内皮细胞部分丢失,中膜层平滑肌增厚,组织学未见明显差异;注射后2 d,聚多卡醇组的中膜损伤率高于鱼肝油酸钠组[(63.6±9.4)% vs.(49.2±4.4)%],差异有统计学意义(P<0.05)。注射后28 d,两组的内皮细胞完全脱落,中膜层平滑肌增厚,甚至延伸至外膜。聚多卡醇组血管壁内皮脱失率随时间延长无明显变化,中膜厚度随时间延长增大,鱼肝油酸钠组血管壁内皮脱失率随时间延长而加重,中膜厚度随时间延长增大。

结论:

聚多卡醇和鱼肝油酸钠均可对血管内皮和中膜造成损伤,长期对血管作用均产生胶原纤维化,聚多卡醇对血管产生纤维化的作用较鱼肝油酸钠大。

Objective:

To compare the histological injury on the inferior saphenous vein of Beagle dogs after DSA-guided injection of two commonly used foam sclerosing agents, such as polycacol and sodium cod liver oil.

Methods:

Twelve Beagle dogs were selected and randomly devided into group A (polidocanol foam injection group) and group B (sodium morrhuat foam injection group) , n=6. DSA fluoroscopy was performed on the saphenous venography. The 1% polydocaine foam sclerosing agent was injected into the left anterior, left posterior and right hind limbs, and 5% cod liver foam sclerosing agent was injected into the left anterior, left posterior and right hind limbs. Saphenous veins were removed after 30 min, 2 d and 28 d of injection and stained by HE or Massion. The histological changes of endothelium and medial membrane of saphenous vein were observed under light microscope.

Results:

Both foam hardeners could cause vascular endothelial injury and thickening of the medial membrane of the wall of canine saphenous vein. After 30 min, the partial loss of endothelial cells and thickening of smooth muscle in the middle layer were observed in both groups, and no significant histological difference was found between the two groups. After 2 d, the membrane damage rate in group A was higher than that in group B[ (63.6±9.4) % vs. (49.2±4.4) %], and the difference was statistically significant (P<0.05) . After 28 d, the endothelial cells of groups A and B were completely exfoliated, and the smooth muscle of the middle layer was thickened and even extended to the outer membrane, with no significant histological difference. There was no significant change in vascular endothelial injury in group A with the extension of time, while the thickness of the median increased with the extension of time; in group B, the vascular endothelial injury increased with the extension of time, and the thickness of the median increased with the extension of time.

Conclusions:

Both polydodecol and sodium ovalerate can cause endothelial and terminal damage to vascular walls, and produce collagen fibrosis. The effect of polydodecol on vascular fibrosis is greater than sodium.

图4 注射聚多卡醇30 min后,红色直线为中膜损伤的深度,蓝色直线为中膜的厚度
图6 聚多卡醇组注射配制的聚多卡醇硬化剂后28 d,可见血管壁增厚,管腔缩小闭塞(HE,×40)
表1 两组注射硬化剂后不同时点的内皮脱失率和中膜损伤率比较 (n=18,%,±s
表2 两组注射硬化剂后的中膜厚度比较 (n=18,μm,±s
[1]
梁奇伟,冯惠岗,庄炜钊,等.透视下聚多卡醇硬化治疗C5~C6期下肢静脉性溃疡的疗效[J].中华介入放射学电子杂志,2016,4(4):216-220.
[2]
Lin F, Zhang SY, Sun Y,et al. The management of varicose veins[J]. Int Surg,2015,100(1):185-189.
[3]
叶志东,刘鹏,阎正明,等.腔内射频消融静脉闭合联合透光直视旋切术微创治疗下肢静脉曲张[J].中日友好医院学报,2004,18(4):204-206.
[4]
Belcaro G, Cesarone MR, Di Renzo A,et al. Foam-sclerotherapy,surgery,sclerotherapy,and combined treatment for varicose veins: a 10-year,prospective,randomized,controlled,trial(VEDICO trial)[J]. Angiology,2003,54(3):307-315.
[5]
van den Bos R, Arends L, Kockaert M,et al. Endovenous therapies of lower extremity varicosities: a meta-analysis[J]. J Vasc Surg,2009,49(1):230-239.
[6]
Beasley K. Sclerotherapy and Vein Treatment,Second Edition SET,[J]. Open University Press,2012.
[7]
Lawaetz M, Serup J, Lawaetz B,et al. Comparison of endovenous ablation techniques,foam sclerotherapy and surgical stripping for great saphenous varicose veins. Extended 5-year follow-up of a RCT[J]. Int Angiol,2017,36(3):281-288.
[8]
李龙.《慢性静脉疾病硬化疗法欧洲指南》解读[J].介入放射学杂志,2016,25(9):743-749.
[9]
廖恺.鱼肝油酸钠泡沫硬化剂对兔耳缘静脉损伤的病理学研究[D].南方医科大学,2015.
[1] 赵峰, 张秀军, 马少军, 何亮, 国永飞. 筋膜下穿通静脉断离联合泡沫硬化剂与大隐静脉剥脱术治疗小腿溃疡对照研究[J]. 中华损伤与修复杂志(电子版), 2017, 12(01): 22-26.
[2] 李涛, 朱国献, 杨红伟. 泡沫硬化剂联合静脉旋切术治疗严重下肢静脉曲张的疗效观察[J]. 中华普通外科学文献(电子版), 2019, 13(01): 34-37.
[3] 黄楷, 陈钦昌, 林细霞, 陈志波, 李永辉, 吴文洁, 梁琪琳, 符立奋, 黎洪浩. 高位结扎联合泡沫硬化剂治疗原发性大隐静脉曲张的初步疗效[J]. 中华普通外科学文献(电子版), 2017, 11(06): 422-425.
[4] 张健, 林俊, 沈洪亮, 刘志佳, 张东兴, 吴巍巍, 王强. 自体大隐静脉逆转替代肾动脉或肾静脉自体肾移植二例[J]. 中华移植杂志(电子版), 2021, 15(02): 101-104.
[5] 白纪刚, 吝怡, 刘博, 张力维, 李益行, 樊茜, 吉琳, 于璧欣, 禄彦锋, 朱帕尔·阿达力, 孙健钟, 张勇, 吕毅, 严小鹏. 磁锚定技术辅助减Trocar腹腔镜胆囊切除术的实验研究[J]. 中华肝脏外科手术学电子杂志, 2020, 09(05): 484-487.
[6] 黄宏春, 张海波, 孟敏, 陈芳洁, 王秀敏, 郭长青. 透明帽辅助内镜下泡沫硬化剂治疗内痔的初步研究[J]. 中华结直肠疾病电子杂志, 2020, 09(06): 621-624.
[7] 张骞骞, 郭亚荣, 刘立新, 范慧琴. 比格犬肝损伤时F4/80、IL-6与IGFBPrP1的变化及意义[J]. 中华消化病与影像杂志(电子版), 2017, 07(03): 114-117.
[8] 中国血管瘤血管畸形联盟, 中国医师协会介入医师分会妇儿介入学组. 聚桂醇注射液治疗儿童静脉畸形中国专家共识[J]. 中华介入放射学电子杂志, 2022, 10(04): 349-354.
[9] 王佳讯, 陈毓菁, 梁展鹏, 伍卓强, 邬家明, 林毅迪. 超声引导下聚多卡醇泡沫硬化治疗肾囊肿的临床应用价值[J]. 中华介入放射学电子杂志, 2022, 10(03): 278-282.
[10] 冯惠岗, 张健谊, 梁奇伟, 陈汉威, 唐郁宽, 黄益. 聚多卡醇与鱼肝油酸钠泡沫硬化治疗下肢静脉曲张的疗效差异[J]. 中华介入放射学电子杂志, 2021, 09(03): 270-274.
[11] 左松, 董长宪, 肖莉, 王彦林, 郭晓楠, 任腾飞. 聚多卡醇泡沫硬化治疗儿童Puig'sⅠ型和Ⅱ型肛周静脉畸形临床研究[J]. 中华介入放射学电子杂志, 2021, 09(01): 41-44.
[12] 刘珍银, 李海波, 周少毅, 陈昆山, 牛传强, 张韬, 张靖. 无水乙醇联合聚多卡醇泡沫硬化治疗儿童颌面部静脉畸形的临床研究[J]. 中华介入放射学电子杂志, 2017, 05(04): 235-240.
[13] 黄益, 梁奇伟, 陈汉威, 唐郁宽, 黄晨. 泡沫硬化治疗下肢静脉曲张研究进展[J]. 中华介入放射学电子杂志, 2017, 05(02): 65-69.
[14] 李传威, 葛畅, 程兆云, 刘前进, 孙俊杰, 胡俊龙. 大隐静脉的获取方式对冠状动脉旁路移植术效果的影响[J]. 中华心脏与心律电子杂志, 2022, 10(04): 215-220.
[15] 杨继武, 王辉, 孙乐灿, 廖向群. 腔内射频消融联合泡沫硬化剂治疗下肢静脉曲张的临床效果评价[J]. 中华卫生应急电子杂志, 2019, 05(06): 330-334.
阅读次数
全文


摘要